Newsletter #9
📰 The prostate care news
🎓 Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe
This study has identified 7484 studies on prostate cancer. Of these, 19 studies described the cost effectiveness of PCa screening in Europe. Among these studies, most focussed on risk- and/or age- and/or magnetic resonance imaging (MRI)-based screening in addition to prostate-specific antigen (PSA) testing and compared this with no screening.
🎓 Active surveillance yields similar outcomes to prostate cancer treatment, 10-year data show
According to the principal investigator, Daniel Lin, MD, "the goal of active surveillance for prostate cancer is to reduce unnecessary treatments and side effects among those diagnosed with lower risk cancer while avoiding undertreatment of aggressive disease."
🧬 What's up at Koelis?
🎬 The Role of Imaging in Diagnosing and Staging Prostate Cancer
A panel of experts on prostate cancer introduce themselves and begin the discussion with clinical insights on diagnostic practices and the importance of biopsy and imaging in guiding treatment decisions.
📅 EMPIRE Urology Intern Bootcamp 2024
Over 40 interns got hands-on experience, paving the way for future innovations in prostate health.
Special thanks to Dr. Kovac and Dr. Winer for their leadership and dedication to educating the next generation of urologists!
👥 Let's meet!
We will attempt some congresses in the next few months. Here are some of the events we will attend:
✔️07/28 – FTS (Singapore)
✔️07/28 – Urofair (Singapore)
Our team is looking forward to meeting you!
If you want to know more about prostate care management, medical innovation and fusion biopsy, don't hesistate to contact us ✉️.